ZLAB
Zai Lab Limited American Depositary Shares
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Zai Lab (ZLAB) Stock: Buy, Sell, or Hold?
$26.43
-0.43 (-1.60%)
▼
5d:
+20.36%
30d:
+7.48%
90d:
+3.69%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (26%)
Quality Score
43/100
Position
EXTENDED
30-Day Fair Range
$22.53 – $25.33
Position: EXTENDED
Forward P/E & Valuation
-13.3x
Next 12M consensus est.
Wall Street Target
$34.13
+29.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$21.42 / $29.02
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ZLAB shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ZLAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ZLAB is currently trading at $26.43, which is considered extended relative to its 30-day fair value range of $22.53 to $25.33.
Technical Outlook: Technically, ZLAB is in a strong uptrend. Immediate support is located at $21.42, while resistance sits at $29.02.
Market Sentiment: ZLAB scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $34.12 (+29.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZLAB is in a strong uptrend. Immediate support is located at $21.42, while resistance sits at $29.02.
Market Sentiment: ZLAB scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $34.12 (+29.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$22.53 -
$25.33
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
26.3%
Trading Range & Key Levels
30-Day Trading Range
$22.53 -
$25.33
Current vs Trading Range
EXTENDED
Support Level
$21.42
Resistance Level
$29.02
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.1% below Wall St target ($34.12)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-13.33
Wall Street Target
$34.13
(+29.1%)
Revenue Growth (YoY)
-6.8%
Profit Margin
-44.9%
Share ZLAB Analysis
Share this live ZLAB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 11, 2026 7:58 AM ET
Data refreshes hourly during market hours. Next update: 8:58 AM
Data refreshes hourly during market hours. Next update: 8:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZLAB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 40 SELL |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$302 | 49 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$592 | 37 SELL |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 72 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ZLAB Research Pages
